“jason-rhodes” Archives

in
Entry Author Date Location
Generation Bio Leads a Trio of Biotech Companies Aiming for the Nasdaq 05/22/20 National
Disarm Launches With $30M From Atlas, AbbVie to Battle Neuro Disease 09/19/17 Boston
After Failed Schizophrenia Trial, Forum Pharma To Shutter This Week 06/27/16 Boston
Dunsire, Forum Search For Answers After FDA Halts Alzheimer’s Trial 09/29/15 Boston
East Coast Biotech Roundup: PrecisionFDA, Avitide, Foresight & More 08/07/15 Boston
Dunsire, Forum Pharma Look Beyond Fidelity For Big Alzheimer’s Push 04/22/15 Boston
East Coast Biotech Roundup: Raze, Retrophin, Alnylam, & More 10/16/14 Boston
With $24M and Pharma Backing, Ex Epizyme Prez Aims to “Raze” Tumors 10/14/14 Boston
East Coast Biotech Roundup: Intarcia, Atlas, Visterra, & More 10/06/14 Boston
Well-Traveled Rhodes Leaves Epizyme For Atlas Venture Partnership 09/29/14 Boston
Join Us For “Boston’s Life Science Disruptors” on Oct. 8 08/21/14 Boston
7 Takeaways From “What’s Hot in Boston Biotech” 04/22/14 Boston
What’s Hot in Boston Biotech: Here’s the Agenda for April 16 03/27/14 Boston
Who Should Biotech Pros Follow on Twitter? An Update for 2013 08/19/13 National
East Coast Life Sciences Roundup: Epizyme, Rodin, Ophthotech, & More 08/16/13 Boston
Epizyme Execs Share the Secret to a Successful IPO: PowerBars 08/15/13 Boston
East Coast Life Sciences Roundup: Verdine, Vedanta, Alnylam, & More 07/05/13 Boston
It Takes a Village to Raise a Biotech Startup: Highlights from the Tweetchat 12/06/11 National
Join Us at 3 pm ET/Noon PT for Tweetchat on Biotech Startups 12/05/11 National
Join Us for a Tweetchat Monday on Biotech Startups 12/02/11 National
BIO Investor Forum Roundup: Immune Design, Sorbent Therapeutics, Epizyme 10/26/11 National
Epizyme, Riding High on Two Big Pharma Deals, Zeroes in on Personalized Cancer Therapy 03/29/11 Boston
Epizyme Entices Broad Institute Player, Robert Gould, to Take Over as CEO 03/24/10 Boston
Page 1 of 1